Cargando…

Meta-analysis on outcome-worsening comorbidities of COVID-19 and related potential drug-drug interactions

Drug-drug interactions (DDI) potentially occurring between medications used in the course of COVID-19 infection and medications prescribed for the management of underlying comorbidities may cause adverse drug reactions (ADRs) contributing to worsening of the clinical outcome in affected patients. Fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awortwe, Charles, Cascorbi, Ingolf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550259/ https://www.ncbi.nlm.nih.gov/pubmed/33059010 http://dx.doi.org/10.1016/j.phrs.2020.105250

Ejemplares similares

Pharmacogenetics and Predictive Testing of Drug Hypersensitivity Reactions
por: Böhm, Ruwen, et al.
Publicado: (2016)

Potential drug-drug interactions and their associated factors in hospitalized COVID-19 patients with comorbidities
por: Rahmadani, Imanda Dyah, et al.
Publicado: (2023)

Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
por: Manda, Vamshi K., et al.
Publicado: (2014)

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
por: Back, David, et al.
Publicado: (2020)

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19
por: Mok, Jacob, et al.
Publicado: (2021)

Germline variants in cancer therapy
por: Kaehler, Meike, et al.
Publicado: (2019)

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia
por: Kaehler, Meike, et al.
Publicado: (2021)

Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
por: Afsar, Nasir Ali, et al.
Publicado: (2019)

Inhibitory Interactions of Aspalathus linearis (Rooibos) Extracts and Compounds, Aspalathin and Z-2-(β-d-Glucopyranosyloxy)-3-phenylpropenoic Acid, on Cytochromes Metabolizing Hypoglycemic and Hypolipidemic Drugs
por: Patel, Oelfah, et al.
Publicado: (2016)

Can Coinfection With Influenza Worsen COVID-19 Outcomes?
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Could aquaporin modulators be employed as prospective drugs for COVID-19 related pulmonary comorbidity?
por: Mariajoseph-Antony, Lezy Flora, et al.
Publicado: (2020)

Potential drug–drug interactions in COVID 19 patients in treatment with lopinavir/ritonavir()
por: Brandariz-Nuñez, David, et al.
Publicado: (2020)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

Prevalence of potential drug-drug interactions with ritonavir-containing COVID-19 therapy
por: Igho-Osagie, Ebuwa, et al.
Publicado: (2023)

COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders
por: Conway, Sarah E., et al.
Publicado: (2022)

Comorbid epilepsy and depression—pharmacokinetic and pharmacodynamic drug interactions
por: Miziak, Barbara, et al.
Publicado: (2022)

Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis
por: Liu, Shuang, et al.
Publicado: (2021)

Antimicrobial peptides and proteins of the horse - insights into a well-armed organism
por: Bruhn, Oliver, et al.
Publicado: (2011)

Cardiac arrhythmias in COVID-19 patients: A combination of viral comorbidities and pro-arrhythmic drug interactions
por: Ehrlich, Haley, et al.
Publicado: (2021)

A CASE OF COVID-19 PRESENTING WITH ENCEPHALOPATHY, POST-INFECTIOUS NEUROPSYCHIATRIC SEQUELAE, AND ACCELERATED WORSENING OF CHRONIC COMORBIDITIES
por: DAGOGO-JACK, IBIMINA, et al.
Publicado: (2021)

Drug-drug interactions in patients with COVID-19
Publicado: (2020)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations
por: Ocampo, Adolfo A., et al.
Publicado: (2022)

Multi-omics characterization of RNA binding proteins reveals disease comorbidities and potential drugs in COVID-19
por: Pan, Jiwei, et al.
Publicado: (2023)

PSMA-617 inhibits proliferation and potentiates the (177)Lu-PSMA-617-induced death of human prostate cancer cells
por: Zhao, Yi, et al.
Publicado: (2023)

Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications
por: Jain, Shreshta, et al.
Publicado: (2021)

Potential interactions between COVID-19 vaccines and antiepileptic drugs
por: Kow, Chia Siang, et al.
Publicado: (2021)

COVID-19 patients with hypertension are at potential risk of worsened organ injury
por: Xia, Fei, et al.
Publicado: (2021)

The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes
por: Adu-Agyeiwaah, Yvonne, et al.
Publicado: (2020)

Does Ibuprofen Worsen COVID-19?
por: Moore, Nicholas, et al.
Publicado: (2020)

Predictors of Worsening Oxygenation in COVID-19
por: Oh, Jee Youn
Publicado: (2021)

Predictors of Worsening COVID-19 Illness
por: Joob, Beuy, et al.
Publicado: (2021)

Relationship between drug interactions and drug-related negative clinical outcomes
por: Cremades, Javier, et al.
Publicado: (2009)

Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021)

Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine
por: Ye, Ling, et al.
Publicado: (2023)

Detecting Drug-Drug Interactions in COVID-19 Patients
por: Jeong, Eugene, et al.
Publicado: (2022)

Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
por: Kumar, Devendra, et al.
Publicado: (2021)

Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19
por: Azam, Faizul
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_donhgt1gelkb69t15gk9h93pcq